Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Interest Expense
\$0.00 Mil (TTM As of Mar. 2015)

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Synageva BioPharma Corp's interest expense for the three months ended in Mar. 2015 was \$0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2015 was \$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a companys Operating Income (EBIT) by its Interest Expense. Synageva BioPharma Corp's Operating Income for the three months ended in Mar. 2015 was \$-59.17 Mil. Synageva BioPharma Corp's Interest Expense for the three months ended in Mar. 2015 was \$0.00 Mil. Synageva BioPharma Corp has no debt. The higher the ratio, the stronger the companys financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Definition

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Synageva BioPharma Corp Interest Expense for the trailing twelve months (TTM) ended in Mar. 2015 was 0 (Jun. 2014 ) + 0 (Sep. 2014 ) + 0 (Dec. 2014 ) + 0 (Mar. 2015 ) = \$0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a companys Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Synageva BioPharma Corp's interest expense for the three months ended in Mar. 2015 was \$0.00 Mil. Its operating income for the three months ended in Mar. 2015 was \$-59.17 Mil. And its Long-Term Debt for the three months ended in Mar. 2015 was \$0.00 Mil.

Synageva BioPharma Corp's Interest Coverage for the quarter that ended in Mar. 2015 is calculated as

 Synageva BioPharma Corp had no debt.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

The higher the ratio, the stronger the companys financial strength is.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Interest Expense -0.75 -0.78 -0.64 -0.35 -0.26 0.00 0.00 0.00 0.00 0.00

Synageva BioPharma Corp Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Interest Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)